Allogeneic adipose tissue-derived mesenchymal stromal/stem cells (AdMSC)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Allogeneic adipose tissue-derived mesenchymal stromal/stem cells (AdMSC), covering 2025-01-28 to 2025-01-28. Get the full timeline:
Most recent: Clinical Trial Update: Tolerance Study of Allogeneic of Adipose Tissue Derived Mesenchymal Stroma/Stem Cells (AdMSC) Transplantation in Patients With Critical Limb Ischemia. [Phase 1]